AlectorvsAmgen

ALEC and AMGN stock compared: price, dividend, valuation and results, from SEC filings.

ALEC

Alector, Inc.

$2.33

Value $348M

+1.52%
ALEC's page

AMGN

Amgen Inc.

$435.64

Value $235B

-0.72%
AMGN's page

Alector (ALEC) has a market value of $348M and Amgen (AMGN) $235B. Over the last year, with dividends, ALEC moved +91.8% and AMGN +31.5%. The P/E is 8.4 for ALEC and 25.0 for AMGN. Dividend yield: ALEC none, AMGN 2.31%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ALEC$348M

    AMGN$235B

    AMGN is 676 times ALEC

  • Revenue, 12 months

    ALEC$173M

    AMGN$38.9B

    AMGN is 224 times ALEC

  • Net income, 12 months

    ALEC$41M

    AMGN$9.4B

    AMGN is 227 times ALEC

  • Operating margin

    ALEC20.2%

    AMGN32.4%

    12.2 points apart

  • ROIC

    ALEC56.5%

    AMGN16.2%

    40.3 points apart

  • P/E

    ALEC8.4

    AMGN25.0

    AMGN is 3.0 times ALEC

  • Dividend yield

    ALEC0.0%

    AMGN2.3%

    2.3 points apart

  • 5-year return

    ALEC-89.1%

    AMGN+146.3%

    235.4 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

ALEC-89.1%

AMGN+146.3%

010020020222023202420252026
Returns by period
PeriodALECWith dividendsAMGNWith dividends
1 year since November 19, 2025+91.8%Price +91.8%+31.5%Price +27.2%
3 years since November 20, 2023-52.4%-21.9% a yearPrice -52.4%+79.2%+21.5% a yearPrice +64.2%
5 years since November 19, 2021-89.1%-35.8% a yearPrice -89.1%+146.3%+19.8% a yearPrice +111.4%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ALECAlectorAMGNAmgen

Valuation

ALECAMGN
Valuation
Price$2.33$435.64
Market value$348M$235B
Enterprise value (EV)$209M$276B
P/E8.425.0
P/E, 5-year median–23.0
P/B3.016.4
EV/EBIT6.021.9
Free cash flow yield–4.1%

Results and growth

ALECAMGN
Results and growth
Revenue, 12 months$173M$38.9B
Net income, 12 months$41M$9.4B
Free cash flow, 12 months-$150M$9.6B
Earnings per share, 12 months$0.28$17.25
Revenue growth, year on year-79.1%10.0%
Revenue growth a year, past-0.1%over 5 years+7.6%over 5 years
EPS growth a year, past–+2.9%over 5 years

Margins and returns on capital

ALECAMGN
Margins and returns on capital
Gross margin–70.9%
Operating margin20.2%32.4%
Net margin23.9%24.1%
ROIC56.5%16.2%
ROE100.8%87.8%

Balance sheet

ALECAMGN
Balance sheet
Cash$139M$13.2B
Total debt$21M$54.0B
Net debt / EBITDA-3.42.3
Interest cover–4.8×

Dividends and buybacks

ALECAMGN
Dividends and buybacks
Dividend yield–2.3%
Dividend per share, 12 months–$10.08
Dividend growth a year, past–+8.1%over 5 years
Buyback yield––
Shareholder yield–2.3%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ALEC or AMGN

Didn't find what you were looking for?

Ask us
Which is bigger, Alector or Amgen?

By market value, Amgen ($235B) is about 675.5 times Alector ($348M), at today's prices.

How did ALEC and AMGN stock do over the last 5 years?

Since November 19, 2021, ALEC's price moved -89.1% and AMGN's +111.4%. With dividends: ALEC -89.1% (-35.8% a year), AMGN +146.3% (+19.8% a year). Past returns do not predict future ones.

Which pays the higher dividend, ALEC or AMGN?

The dividend yield at today's price is none for Alector and 2.31% for Amgen. Over the last twelve months they paid – and $10.08 per share.

What is the P/E of ALEC and AMGN?

At today's price, the P/E is 8.4 for ALEC and 25.0 for AMGN. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, Alector or Amgen?

Over the last twelve months, the net margin was 23.9% for Alector and 24.1% for Amgen, and the operating margin 20.2% and 32.4%. Revenue was $173M and $38.9B.

Which is the better investment, Alector or Amgen?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.